Activation of NF-κB by the Kaposi's sarcoma-associated herpesvirus K15 protein involves recruitment of the NF-κB-inducing kinase, IκB kinases, and phosphorylation of p65

Journal of Virology

Volumn 88, Issue 22, 2014, Pages 13161-13172

  Hävemeier, Anika ^a   Gramolelli, Silvia ^a   Pietrek, Marcel ^a   Jochmann, Ramona ^b   Stürzl, Michael ^b   Schulz, Thomas F ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; K15 PROTEIN; NUCLEAR FACTOR KAPPA B INDUCING KINASE; PHOSPHOLIPASE C GAMMA; PROTEIN KINASE; SERINE; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTION FACTOR RELA; UNCLASSIFIED DRUG; VIRUS PROTEIN; CHUK PROTEIN, HUMAN; K15 PROTEIN, HUMAN HERPESVIRUS 8; NF-KAPPA B KINASE; PROTEIN SERINE THREONINE KINASE; RELA PROTEIN, HUMAN; VIRAL PROTEIN;

ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; ENZYME ACTIVATION; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; NONHUMAN; PROTEIN DOMAIN; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; TRANSCRIPTION INITIATION; CELL LINE; IMMUNOLOGY; METABOLISM; PHOSPHORYLATION; PROTEIN PROCESSING;

CELL LINE; HERPESVIRUS 8, HUMAN; HUMANS; I-KAPPA B KINASE; NF-KAPPA B; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN-SERINE-THREONINE KINASES; TRANSCRIPTION FACTOR RELA; VIRAL PROTEINS;

EID: 84908374503     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01766-14     Document Type: Article

References (77)

1. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, Moore PS. 1994. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266:1865-1869. http://dx.doi.org/10.1126/science.7997879.
2. Moore PS, Chang Y. 1995. Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and withoutHIVinfection. N. Engl. J. Med. 332:1181-1185. http://dx.doi.org/10.1056/NEJM199505043321801.
3. Schulz TF. 2001. KSHV/HHV8-associated lymphoproliferations in the AIDS setting. Eur. J. Cancer 37:1217-1226. http://dx.doi.org/10.1016/S0959-8049(01)00115-0.
4. Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM. 1995. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N. Engl. J. Med. 332:1186-1191. http://dx.doi.org/10.1056/NEJM199505043321802.
5. Soulier J, Grollet L, Oksenhendler E, Cacoub P, Cazals-Hatem D, Babinet P, d'Agay MF, Clauvel JP, Raphael M, Degos L, Sigaux F. 1995. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood 86:1276-1280.
6. Boshoff C, Schulz TF, Kennedy MM, Graham AK, Fisher C, Thomas A, McGee JO, Weiss RA, O'Leary JJ. 1995. Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells. Nat. Med. 1:1274-1278. http://dx.doi.org/10.1038/nm1295-1274.
7. Dupin N, Fisher C, Kellam P, Ariad S, Tulliez M, Franck N, van Marck E, Salmon D, Gorin I, Escande JP, Weiss RA, Alitalo K, Boshoff C. 1999. Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma. Proc. Natl. Acad. Sci. U. S. A. 96:4546-4551. http://dx.doi.org/10.1073/pnas.96.8.4546.
8. Katano H, Sato Y, Kurata T, Mori S, Sata T. 2000. Expression and localization of human herpesvirus 8-encoded proteins in primary effusion lymphoma, Kaposi's sarcoma, and multicentric Castleman's disease. Virology 269:335-344. http://dx.doi.org/10.1006/viro.2000.0196.
9. Parravicini C, Chandran B, Corbellino M, Berti E, Paulli M, Moore PS, Chang Y. 2000. Differential viral protein expression in Kaposi's sarcomaassociated herpesvirus-infected diseases: Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease. Am. J. Pathol. 156: 743-749. http://dx.doi.org/10.1016/S0002-9440(10)64940-1.
10. Rainbow L, Platt GM, Simpson GR, Sarid R, Gao SJ, Stoiber H, Herrington CS, Moore PS, Schulz TF. 1997. The 222-to 234-kilodalton latent nuclear protein (LNA) of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) is encoded by orf73 and is a component of the latency-associated nuclear antigen. J. Virol. 71:5915-5921.
11. Blasig C, Zietz C, Haar B, Neipel F, Esser S, Brockmeyer NH, Tschachler E, Colombini S, Ensoli B, Sturzl M. 1997. Monocytes in Kaposi's sarcoma lesions are productively infected by human herpesvirus. 8. J. Virol. 71:7963-7968.
12. Chiou CJ, Poole LJ, Kim PS, Ciufo DM, Cannon JS, ap Rhys CM, Alcendor DJ, Zong JC, Ambinder RF, Hayward GS. 2002. Patterns of gene expression and a transactivation function exhibited by the vGCR (ORF74) chemokine receptor protein of Kaposi's sarcoma-associated herpesvirus. J. Virol. 76:3421-3439. http://dx.doi.org/10.1128/JVI.76.7.3421-3439.2002.
13. Choi JK, Lee BS, Shim SN, Li M, Jung JU. 2000. Identification of the novel K15 gene at the rightmost end of the Kaposi's sarcoma-associated herpesvirus genome. J. Virol. 74:436-446. http://dx.doi.org/10.1128/JVI.74.1.436-446.2000.
14. Glenn M, Rainbow L, Aurade F, Davison A, Schulz TF. 1999. Identification of a spliced gene from Kaposi's sarcoma-associated herpesvirus encoding a protein with similarities to latent membrane proteins 1 and 2A of Epstein-Barr virus. J. Virol. 73:6953-6963.
15. Poole LJ, Zong JC, Ciufo DM, Alcendor DJ, Cannon JS, Ambinder R, Orenstein JM, Reitz MS, Hayward GS. 1999. Comparison of genetic variability at multiple loci across the genomes of the major subtypes of Kaposi's sarcoma-associated herpesvirus reveals evidence for recombination and for two distinct types of open reading frame K15 alleles at the right-hand end. J. Virol. 73:6646-6660.
16. Bala K, Bosco R, Gramolelli S, Haas DA, Kati S, Pietrek M, Havemeier A, Yakushko Y, Singh VV, Dittrich-Breiholz O, Kracht M, Schulz TF. 2012. Kaposi's sarcoma herpesvirus K15 protein contributes to virusinduced angiogenesis by recruiting PLCgamma1 and activating NFAT1-dependent RCAN1 expression. PLoS Pathog. 8:e1002927. http://dx.doi.org/10.1371/journal.ppat.1002927.
17. Brinkmann MM, Glenn M, Rainbow L, Kieser A, Henke-Gendo C, Schulz TF. 2003. Activation of mitogen-activated protein kinase and NFkappaB pathways by a Kaposi's sarcoma-associated herpesvirus K15 membrane protein. J. Virol. 77:9346-9358. http://dx.doi.org/10.1128/JVI.77.17.9346-9358.2003.
18. Brinkmann MM, Pietrek M, Dittrich-Breiholz O, Kracht M, Schulz TF. 2007. Modulation of host gene expression by the K15 protein of Kaposi's sarcoma-associated herpesvirus. J. Virol. 81:42-58. http://dx.doi.org/10.1128/JVI.00648-06.
19. Siebenlist U, Franzoso G, Brown K. 1994. Structure, regulation and function of NF-kappa B. Annu. Rev. Cell Biol. 10:405-455. http://dx.doi.org/10.1146/annurev.cb.10.110194.002201.
20. Baldwin AS, Jr. 1996. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu. Rev. Immunol. 14:649-683. http://dx.doi.org/10.1146/annurev.immunol.14.1.649.
21. Karin M, Delhase M. 2000. The I kappa B kinase (IKK) and NF-kappa B: key elements of proinflammatory signalling. Semin. Immunol. 12:85-98. http://dx.doi.org/10.1006/smim.2000.0210.
22. Bonizzi G, Karin M. 2004. The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol. 25:280-288. http://dx.doi.org/10.1016/j.it.2004.03.008.
23. Hayden MS, Ghosh S. 2004. Signaling to NF-kappaB. Genes Dev. 18: 2195-2224. http://dx.doi.org/10.1101/gad.1228704.
24. Karin M, Lin A. 2002. NF-kappaB at the crossroads of life and death. Nat. Immunol. 3:221-227. http://dx.doi.org/10.1038/ni0302-221.
25. Silverman N, Maniatis T. 2001. NF-kappaB signaling pathways in mammalian and insect innate immunity. Genes Dev. 15:2321-2342. http://dx.doi.org/10.1101/gad.909001.
26. Claudio E, Brown K, Park S, Wang H, Siebenlist U. 2002. BAFF-induced NEMO-independent processing of NF-kappa B2 in maturing B cells. Nat. Immunol. 3:958-965. http://dx.doi.org/10.1038/ni842.
27. Coope HJ, Atkinson PG, Huhse B, Belich M, Janzen J, Holman MJ, Klaus GG, Johnston LH, Ley SC. 2002. CD40 regulates the processing of NF-kappaB2 p100 to p52. EMBO J. 21:5375-5385. http://dx.doi.org/10.1093/emboj/cdf542.
28. Dejardin E, Droin NM, Delhase M, Haas E, Cao Y, Makris C, Li ZW, Karin M, Ware CF, Green DR. 2002. The lymphotoxin-beta receptor induces different patterns of gene expression via two NF-kappaB pathways. Immunity 17:525-535. http://dx.doi.org/10.1016/S1074-7613(02) 00423-5.
29. Kayagaki N, Yan M, Seshasayee D, Wang H, Lee W, French DM, Grewal IS, Cochran AG, Gordon NC, Yin J, Starovasnik MA, Dixit VM. 2002. BAFF/BLyS receptor 3 binds the B cell survival factor BAFF ligand through a discrete surface loop and promotes processing of NF-kappaB2. Immunity 17:515-524. http://dx.doi.org/10.1016/S1074-7613(02)00425-9.
30. Senftleben U, Cao Y, Xiao G, Greten FR, Krahn G, Bonizzi G, Chen Y, Hu Y, Fong A, Sun SC, Karin M. 2001. Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway. Science 293:1495-1499. http://dx.doi.org/10.1126/science.1062677.
31. Shinkura R, Kitada K, Matsuda F, Tashiro K, Ikuta K, Suzuki M, Kogishi K, Serikawa T, Honjo T. 1999. Alymphoplasia is caused by a point mutation in the mouse gene encoding Nf-kappa b-inducing kinase. Nat. Genet. 22:74-77. http://dx.doi.org/10.1038/8780.
32. Yilmaz ZB, Weih DS, Sivakumar V, Weih F. 2003. RelB is required for Peyer's patch development: differential regulation of p52-RelB by lymphotoxin and TNF. EMBO J. 22:121-130. http://dx.doi.org/10.1093/emboj/cdg004.
33. Yin L, Wu L, Wesche H, Arthur CD, White JM, Goeddel DV, Schreiber RD. 2001. Defective lymphotoxin-beta receptor-induced NF-kappaB transcriptional activity in NIK-deficient mice. Science 291:2162-2165. http://dx.doi.org/10.1126/science.1058453.
34. Ling L, Cao Z, Goeddel DV. 1998. NF-kappaB-inducing kinase activates IKK-alpha by phosphorylation of Ser-176. Proc. Natl. Acad. Sci. U. S. A. 95:3792-3797. http://dx.doi.org/10.1073/pnas.95.7.3792.
35. Xiao G, Harhaj EW, Sun SC. 2001. NF-kappaB-inducing kinase regulates the processing of NF-kappaB2 p100. Mol. Cell 7:401-409. http://dx.doi.org/10.1016/S1097-2765(01)00187-3.
36. Schmitz ML, dos Santos Silva MA, Baeuerle PA. 1995. Transactivation domain 2 (TA2) of p65 NF-kappa B. Similarity to TA1 and phorbol esterstimulated activity and phosphorylation in intact cells. J. Biol. Chem. 270: 15576-15584.
37. Schmitz ML, Stelzer G, Altmann H, Meisterernst M, Baeuerle PA. 1995. Interaction of the COOH-terminal transactivation domain of p65 NFkappa B with TATA-binding protein, transcription factor IIB, and coactivators. J. Biol. Chem. 270:7219-7226. http://dx.doi.org/10.1074/jbc.270.13.7219.
38. Wang D, Baldwin AS, Jr. 1998. Activation of nuclear factor-kappaBdependent transcription by tumor necrosis factor-alpha is mediated through phosphorylation of RelA/p65 on serine 529. J. Biol. Chem. 273: 29411-29416. http://dx.doi.org/10.1074/jbc.273.45.29411.
39. Wang D, Westerheide SD, Hanson JL, Baldwin AS, Jr. 2000. Tumor necrosis factor alpha-induced phosphorylation of RelA/p65 on Ser529 is controlled by casein kinase II. J. Biol. Chem. 275:32592-32597. http://dx.doi.org/10.1074/jbc.M001358200.
40. Mattioli I, Sebald A, Bucher C, Charles RP, Nakano H, Doi T, Kracht M, Schmitz ML. 2004. Transient and selective NF-kappa B p65 serine 536 phosphorylation induced by T cell costimulation is mediated by I kappa B kinase beta and controls the kinetics of p65 nuclear import. J. Immunol. 172:6336-6344. http://dx.doi.org/10.4049/jimmunol.172.10.6336.
41. Sakurai H, Chiba H, Miyoshi H, Sugita T, Toriumi W. 1999. IkappaB kinases phosphorylate NF-kappaB p65 subunit on serine 536 in the transactivation domain. J. Biol. Chem. 274:30353-30356. http://dx.doi.org/10.1074/jbc.274.43.30353.
42. Jiang X, Takahashi N, Matsui N, Tetsuka T, Okamoto T. 2003. The NF-kappa B activation in lymphotoxin beta receptor signaling depends on the phosphorylation of p65 at serine 536. J. Biol. Chem. 278:919-926. http://dx.doi.org/10.1074/jbc.M208696200.
43. Nakshatri H, Bhat-Nakshatri P, Martin DA, Goulet RJ, Jr, Sledge GW, Jr. 1997. Constitutive activation of NF-kappaB during progression of breast cancer to hormone-independent growth. Mol. Cell. Biol. 17:3629-3639.
44. Neumann M, Grieshammer T, Chuvpilo S, Kneitz B, Lohoff M, Schimpl A, Franza BR, Jr, Serfling E. 1995. RelA/p65 is a molecular target for the immunosuppressive action of protein kinase A. EMBO J. 14:1991-2004.
45. Rayet B, Gelinas C. 1999. Aberrant rel/nfkb genes and activity in human cancer. Oncogene 18:6938-6947. http://dx.doi.org/10.1038/sj.onc.1203221.
46. Eliopoulos AG, Caamano JH, Flavell J, Reynolds GM, Murray PG, Poyet JL, Young LS. 2003. Epstein-Barr virus-encoded latent infection membrane protein 1 regulates the processing of p100 NF-kappaB2 to p52 via an IKKgamma/NEMO-independent signalling pathway. Oncogene 22:7557-7569. http://dx.doi.org/10.1038/sj.onc.1207120.
47. Eliopoulos AG, Young LS. 2001. LMP1 structure and signal transduction. Semin. Cancer Biol. 11:435-444. http://dx.doi.org/10.1006/scbi.2001.0410.
48. Mosialos G. 2001. Cytokine signaling and Epstein-Barr virus-mediated cell transformation. Cytokine Growth Factor Rev. 12:259-270. http://dx.doi.org/10.1016/S1359-6101(00)00035-6.
49. Schultheiss U, Puschner S, Kremmer E, Mak TW, Engelmann H, Hammerschmidt W, Kieser A. 2001. TRAF6 is a critical mediator of signal transduction by the viral oncogene latent membrane protein 1. EMBO J. 20:5678-5691. http://dx.doi.org/10.1093/emboj/20.20.5678.
50. Luftig M, Prinarakis E, Yasui T, Tsichritzis T, Cahir-McFarland E, Inoue J, Nakano H, Mak TW, Yeh WC, Li X, Akira S, Suzuki N, Suzuki S, Mosialos G, Kieff E. 2003. Epstein-Barr virus latent membrane protein 1 activation of NF-kappaB through IRAK1 and TRAF6. Proc. Natl. Acad. Sci. U. S. A. 100: 15595-15600. http://dx.doi.org/10.1073/pnas.2136756100.
51. Shkoda A, Town JA, Griese J, Romio M, Sarioglu H, Knofel T, Giehler F, Kieser A. 2012. The germinal center kinase TNIK is required for canonical NF-kappaB and JNK signaling in B-cells by the EBV oncoprotein LMP1 and the CD40 receptor. PLoS Biol. 10:e1001376. http://dx.doi.org/10.1371/journal.pbio.1001376.
52. Lee H, Choi JK, Li M, Kaye K, Kieff E, Jung JU. 1999. Role of cellular tumor necrosis factor receptor-associated factors in NF-kappaB activation and lymphocyte transformation by herpesvirus Saimiri STP. J. Virol. 73: 3913-3919.
53. Sorokina EM, Merlo JJ, Jr, Tsygankov AY. 2004. Molecular mechanisms of the effect of herpesvirus saimiri protein StpC on the signaling pathway leading to NF-kappaB activation. J. Biol. Chem. 279:13469-13477. http://dx.doi.org/10.1074/jbc.M305250200.
54. Heinemann S, Biesinger B, Fleckenstein B, Albrecht JC. 2006. NFkappaB signaling is induced by the oncoprotein Tio through direct interaction with TRAF6. J. Biol. Chem. 281:8565-8572. http://dx.doi.org/10.1074/jbc.M510891200.
55. de Jong SJ, Albrecht JC, Schmidt M, Muller-Fleckenstein I, Biesinger B. 2010. Activation of noncanonical NF-kappaB signaling by the oncoprotein Tio. J. Biol. Chem. 285:16495-16503. http://dx.doi.org/10.1074/jbc.M110.102848.
56. Choudhary S, Boldogh S, Garofalo R, Jamaluddin M, Brasier AR. 2005. Respiratory syncytial virus influences NF-kappaB-dependent gene expression through a novel pathway involving MAP3K14/NIK expression and nuclear complex formation with NF-kappaB2. J. Virol. 79:8948-8959. http://dx.doi.org/10.1128/JVI.79.14.8948-8959.2005.
57. Liu P, Li K, Garofalo RP, Brasier AR. 2008. Respiratory syncytial virus induces RelA release from cytoplasmic 100-kDa NF-kappa B2 complexes via a novel retinoic acid-inducible gene-I{middle dot}NF-kappa B-inducing kinase signaling pathway. J. Biol. Chem. 283:23169-23178. http://dx.doi.org/10.1074/jbc.M802729200.
58. Uhlik M, Good L, Xiao G, Harhaj EW, Zandi E, Karin M, Sun SC. 1998.NF-kappaB-inducing kinase and IkappaB kinase participate in human T-cell leukemia virus I Tax-mediated NF-kappaB activation. J. Biol. Chem. 273:21132-21136. http://dx.doi.org/10.1074/jbc.273.33.21132.
59. Leghmari K, Bennasser Y, Bahraoui E. 2008. HIV-1 Tat protein induces IL-10 production in monocytes by classical and alternative NF-kappaB pathways. Eur. J. Cell Biol. 87:947-962. http://dx.doi.org/10.1016/j.ejcb.2008.06.005.
60. Konrad A, Wies E, Thurau M, Marquardt G, Naschberger E, Hentschel S, Jochmann R, Schulz TF, Erfle H, Brors B, Lausen B, Neipel F, Sturzl M. 2009. A systems biology approach to identify the combination effects of human herpesvirus 8 genes on NF-kappaB activation. J. Virol. 83:2563-2574. http://dx.doi.org/10.1128/JVI.01512-08.
61. Matta H, Mazzacurati L, Schamus S, Yang T, Sun Q, Chaudhary PM. 2007. Kaposi's sarcoma-associated herpesvirus (KSHV) oncoprotein K13 bypasses TRAFs and directly interacts with the IkappaB kinase complex to selectively activate NF-kappaB without JNK activation. J. Biol. Chem. 282: 24858-24865. http://dx.doi.org/10.1074/jbc.M700118200.
62. Alkharsah KR, Singh VV, Bosco R, Santag S, Grundhoff A, Konrad A, Sturzl M, Wirth D, Dittrich-Breiholz O, Kracht M, Schulz TF. 2011. Deletion of Kaposi's sarcoma-associated herpesvirus FLICE inhibitory protein, vFLIP, from the viral genome compromises the activation of STAT1-responsive cellular genes and spindle cell formation in endothelial cells. J. Virol. 85:10375-10388. http://dx.doi.org/10.1128/JVI.00226-11.
63. Holtmann H, Winzen R, Holland P, Eickemeier S, Hoffmann E, Wallach D, Malinin NL, Cooper JA, Resch K, Kracht M. 1999. Induction of interleukin-8 synthesis integrates effects on transcription andmRNAdegradation from at least three different cytokine-or stress-activated signal transduction pathways. Mol. Cell. Biol. 19:6742-6753.
64. Huen DS, Henderson SA, Croom-Carter D, Rowe M. 1995. The Epstein-Barr virus latent membrane protein-1 (LMP1) mediates activation of NFkappa B and cell surface phenotype via two effector regions in its carboxyterminal cytoplasmic domain. Oncogene 10:549-560.
65. Eliopoulos AG, Stack M, Dawson CW, Kaye KM, Hodgkin L, Sihota S, Rowe M, Young LS. 1997. Epstein-Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-kappaB pathway involving TNF receptor-associated factors. Oncogene 14:2899-2916. http://dx.doi.org/10.1038/sj.onc.1201258.
66. Kobori M, Yang Z, Gong D, Heissmeyer V, Zhu H, Jung YK, Gakidis MA, Rao A, Sekine T, Ikegami F, Yuan C, Yuan J. 2004. Wedelolactone suppresses LPS-induced caspase-11 expression by directly inhibiting the IKK complex. Cell Death Differ. 11:123-130. http://dx.doi.org/10.1038/sj.cdd.4401325.
67. Sanjo H, Zajonc DM, Braden R, Norris PS, Ware CF. 2010. Allosteric regulation of the ubiquitin:NIK and ubiquitin:TRAF3 E3 ligases by the lymphotoxin-beta receptor. J. Biol. Chem. 285:17148-17155. http://dx.doi.org/10.1074/jbc.M110.105874.
68. Ramakrishnan P, Wang W, Wallach D. 2004. Receptor-specific signaling for both the alternative and the canonical NF-kappaB activation pathways by NF-kappaB-inducing kinase. Immunity 21:477-489. http://dx.doi.org/10.1016/j.immuni.2004.08.009.
69. Hiscott J, Nguyen TL, Arguello M, Nakhaei P, Paz S. 2006. Manipulation of the nuclear factor-kappaB pathway and the innate immune response by viruses. Oncogene 25:6844-6867. http://dx.doi.org/10.1038/sj.onc.1209941.
70. Matsushima A, Kaisho T, Rennert PD, Nakano H, Kurosawa K, Uchida D, Takeda K, Akira S, Matsumoto M. 2001. Essential role of nuclear factor (NF)-kappaB-inducing kinase and inhibitor of kappaB (IkappaB) kinase alpha in NF-kappaB activation through lymphotoxin beta receptor, but not through tumor necrosis factor receptor I. J. Exp. Med. 193:631-636. http://dx.doi.org/10.1084/jem.193.5.631.
71. Joo M, Hahn YS, Kwon M, Sadikot RT, Blackwell TS, Christman JW. 2005. Hepatitis C virus core protein suppresses NF-kappaB activation and cyclooxygenase-2 expression by direct interaction with IkappaB kinase beta. J. Virol. 79:7648-7657. http://dx.doi.org/10.1128/JVI.79.12.7648-7657.2005.
72. Luftig M, Yasui T, Soni V, Kang MS, Jacobson N, Cahir-McFarland E, Seed B, Kieff E. 2004. Epstein-Barr virus latent infection membrane protein 1 TRAF-binding site induces NIK/IKK alpha-dependent noncanonical NF-kappaB activation. Proc. Natl. Acad. Sci. U. S. A. 101:141-146. http://dx.doi.org/10.1073/pnas.2237183100.
73. Pietrek M, Brinkmann MM, Glowacka I, Enlund A, Havemeier A, Dittrich-Breiholz O, Kracht M, Lewitzky M, Saksela K, Feller SM, Schulz TF. 2010. Role of the Kaposi's sarcoma-associated herpesvirus K15 SH3 binding site in inflammatory signaling and B-cell activation. J. Virol. 84:8231-8240. http://dx.doi.org/10.1128/JVI.01696-09.
74. Chu ZL, Shin YA, Yang JM, DiDonato JA, Ballard DW. 1999. IKKgamma mediates the interaction of cellular IkappaB kinases with the tax transforming protein of human T cell leukemia virus type 1. J. Biol. Chem. 274:15297-15300. http://dx.doi.org/10.1074/jbc.274.22.15297.
75. Field N, Low W, Daniels M, Howell S, Daviet L, Boshoff C, Collins M. 2003. KSHV vFLIP binds to IKK-gamma to activate IKK. J. Cell Sci. 116: 3721-3728. http://dx.doi.org/10.1242/jcs.00691.
76. Harhaj EW, Sun SC. 1999. IKKgamma serves as a docking subunit of the IkappaB kinase (IKK) and mediates interaction of IKK with the human T-cell leukemia virus Tax protein. J. Biol. Chem. 274:22911-22914. http://dx.doi.org/10.1074/jbc.274.33.22911.
77. Jin DY, Giordano V, Kibler KV, Nakano H, Jeang KT. 1999. Role of adapter function in oncoprotein-mediated activation of NF-kappaB. Human T-cell leukemia virus type I Tax interacts directly with IkappaB kinase gamma. J. Biol. Chem. 274:17402-17405.